Marshall Wace, LLP Pulse Biosciences, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 13,500 shares of PLSE stock, worth $151,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,500
Previous 26,532
49.12%
Holding current value
$151,065
Previous $324,000
63.89%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PLSE
# of Institutions
67Shares Held
4.72MCall Options Held
239KPut Options Held
94.2K-
Black Rock Inc. New York, NY1.04MShares$11.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA847KShares$9.48 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC780KShares$8.72 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA391KShares$4.37 Million0.0% of portfolio
-
State Street Corp Boston, MA350KShares$3.91 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $415M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...